NCT02712411View on ClinicalTrials.gov

Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

September 30, 2015

Conditions
Erectile DysfunctionProstatic Hyperplasia
Interventions
DRUG

HCP1303

DRUG

HGP1201

DRUG

HIP1402

Trial Locations (1)

03722

Yonsei University Health System, Severance Hospital, Seodaemun-Gu

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT02712411 - Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter